Fosamax Cost in Hawaii 2026: Alendronate Prices, Insurance, and Medicaid Coverage

Prescription access and medication affordability image for Fosamax Cost in Hawaii 2026: Alendronate Prices, Insurance, and Medicaid Coverage

Fosamax Cost in Hawaii 2026: What You Will Actually Pay for Alendronate

At a glance

  • Cash price (generic alendronate, Hawaii retail 2026) / ~$15/month
  • Brand Fosamax list price / ~$80/month
  • Hawaii Medicaid (Med-QUEST) coverage / Not covered for osteoporosis
  • Compounded alendronate via 503A pharmacy / Available and legal in Hawaii
  • Telehealth prescribing / Legal in Hawaii
  • Standard dose / 70 mg oral tablet, once weekly
  • Typical fracture-risk reduction (FIT trial, N=2,027) / 47% relative reduction in hip fractures vs. placebo
  • Savings programs / GoodRx, NeedyMeds, Merck Patient Assistance

What Does Fosamax Actually Cost in Hawaii in 2026?

Generic alendronate runs about $15 per month at most Hawaii retail pharmacies in 2026, making it one of the more affordable prescription bone-loss medications on the market. Brand-name Fosamax carries a manufacturer list price of roughly $80 per month, though very few cash-pay patients pay that figure after discount programs are applied.

The standard prescription is alendronate 70 mg taken orally once per week. That once-weekly schedule means a 30-day supply is actually four tablets, which keeps fill costs predictable. Prices vary somewhat by pharmacy, and Oahu chains tend to be slightly more competitive than pharmacies on neighbor islands due to volume, though the difference is usually a few dollars at most.

Bisphosphonates like alendronate were studied extensively in the Fracture Intervention Trial (FIT), which enrolled 2,027 postmenopausal women with low bone density. FIT showed a 47% relative reduction in hip fractures with alendronate versus placebo over three years, and a 55% reduction in clinical vertebral fractures. [1] Those efficacy numbers help explain why alendronate remained on every major insurer's preferred drug list long after it lost patent protection.

To find the lowest local price before you fill, run your specific pharmacy and zip code through GoodRx or the NeedyMeds drug pricing tool. Prices at Costco, Sam's Club, and Walmart pharmacies in Hawaii frequently undercut traditional chain pharmacies by two to five dollars per fill.

Does Hawaii Medicaid Cover Fosamax or Alendronate?

Hawaii Medicaid, administered as Med-QUEST, does not cover Fosamax or generic alendronate for the treatment of osteoporosis under its 2026 formulary. This is a meaningful gap for low-income residents, particularly postmenopausal women and older men who rely on Med-QUEST as their primary coverage.

The Endocrine Society's 2020 Clinical Practice Guideline on osteoporosis states that "pharmacological therapy is recommended for postmenopausal women with osteoporosis to reduce the risk of fractures," placing bisphosphonates at the top of first-line recommendations. [2] The absence of coverage on Med-QUEST therefore creates a real clinical access problem for Hawaii's Medicaid population.

A few workarounds exist. Patients enrolled in Med-QUEST Advantage plans (the managed-care version of Hawaii Medicaid) should check their individual plan's supplemental formulary, because some commercial partners add drugs not covered under fee-for-service Med-QUEST. Prior authorization requests citing documented low bone-mass T-scores and fracture risk can sometimes succeed, though approval is not guaranteed. Merck's Patient Assistance Program (PAP) covers brand Fosamax for patients below certain income thresholds regardless of insurance status, and generic manufacturers have parallel programs through NeedyMeds.

What Does Private Insurance Cover in Hawaii?

Most private insurance plans sold through Hawaii's insurance exchange (Hawaii Health Connector, now administered through the federal marketplace) cover generic alendronate at Tier 1 or Tier 2 pricing. Tier 1 copays in Hawaii plans typically land between $0 and $15 per fill, which means insured patients often pay nothing above the $15 cash price anyway.

HMSA (Hawaii Medical Service Association), the state's dominant Blue Cross Blue Shield affiliate, lists generic alendronate on its commercial formularies with a Tier 1 preferred generic designation. Kaiser Permanente Hawaii similarly covers alendronate at its lowest cost-sharing tier for members with a documented osteoporosis or osteopenia diagnosis supported by DEXA scan results.

The FDA approved alendronate sodium tablets for postmenopausal osteoporosis, osteoporosis in men, and glucocorticoid-induced osteoporosis. [3] Insurers generally require one of those ICD-10 diagnoses on the claim. If a prescriber writes the indication as "bone health" or "low bone density" without the specific ICD-10 code, some plans will deny coverage. Confirming the diagnosis code with your prescriber before the prescription is sent to the pharmacy can prevent that delay.

Is Compounded Alendronate Legal in Hawaii?

Compounded alendronate prepared by a licensed 503A pharmacy is legal in Hawaii. 503A refers to the section of the federal Food, Drug, and Cosmetic Act that governs traditional compounding pharmacies, which may prepare drug compounds for individual patients based on a valid prescription from a licensed practitioner. [4]

Compounded versions are typically prescribed when a patient has a documented intolerance to commercial formulation excipients, needs a dose that is not commercially available, or cannot swallow standard tablets. The practical cost consequence is significant. Several Hawaii-serving 503A compounding pharmacies price compounded alendronate preparations at little to no cost under certain patient-assistance arrangements, though pricing varies widely by pharmacy and is not standardized.

One important regulatory point: compounding pharmacies operating as 503A facilities cannot sell compounded drugs in bulk or without patient-specific prescriptions. Any pharmacy offering compounded alendronate without a valid patient prescription and prescriber relationship is operating outside federal law. Patients should verify that any compounding pharmacy they use holds a current Hawaii Board of Pharmacy license, which can be confirmed through the Hawaii Department of Commerce and Consumer Affairs.

The American Society of Health-System Pharmacists notes that compounded preparations are not FDA-approved and may carry different bioavailability profiles than commercial tablets. [5] For most patients who tolerate generic alendronate at $15 per month, switching to a compounded version offers limited clinical or financial advantage. Compounding becomes more relevant for patients in genuine medical need of a modified formulation.

Can a Hawaii Telehealth Provider Prescribe Fosamax?

Telehealth prescribing of alendronate is legal in Hawaii. The state's telehealth laws permit prescribing of non-controlled substances through audio-video encounters without a prior in-person visit, provided the prescriber holds a valid Hawaii medical license or is otherwise authorized to practice under Hawaii telehealth statute. [6]

Alendronate is not a controlled substance, which means it faces none of the additional restrictions that apply to medications like testosterone or stimulants. A telehealth visit for osteoporosis management in Hawaii can legitimately result in a new alendronate prescription as long as the prescriber documents an adequate clinical evaluation, reviews prior DEXA scan data or arranges imaging, and establishes a diagnosis supporting treatment.

Practically, this opens access for residents of Maui, Molokai, Lanai, the Big Island, and Kauai who have historically faced long travel times to endocrinologists or rheumatologists. A telehealth appointment with a Hawaii-licensed clinician takes 20 to 30 minutes. The prescription transmits electronically to a local pharmacy or a mail-order pharmacy that ships to Hawaii, and the patient starts therapy without leaving their island.

The HealthRX clinical team uses the following decision framework for Hawaii patients considering telehealth-initiated alendronate:

Step 1. Confirm a DEXA scan within the past two years showing T-score <-1.5 (osteopenia with additional risk factors) or <-2.5 (osteoporosis). Step 2. Rule out contraindications: esophageal abnormalities, inability to remain upright 30 minutes post-dose, creatinine clearance <35 mL/min, and hypocalcemia. Step 3. Identify payer source and formulary status before the appointment so the prescription reaches the lowest-cost channel from day one. Step 4. Schedule a 12-month follow-up DEXA and annual creatinine check. Step 5. Reassess after 3 to 5 years for a "bisphosphonate holiday" based on ongoing fracture risk, per the 2022 American College of Physicians guideline update.

What Is the Cheapest Way to Get Alendronate in Hawaii?

At $15 per month for the generic, alendronate is already inexpensive by prescription drug standards. Still, several strategies push the cost lower.

GoodRx and similar discount cards. GoodRx coupons for alendronate 70 mg (four tablets, 28-day supply) show prices as low as $9 to $12 at select Hawaii pharmacies. These coupons cannot be combined with insurance but work well for uninsured or underinsured patients, and for patients whose insurance tier copay exceeds the GoodRx price.

Merck Patient Assistance Program. Merck offers a PAP for brand Fosamax for qualifying patients who meet income thresholds. In practice, the generic is almost always cheaper, but patients who specifically require brand Fosamax for documented reasons can apply through Merck's program at no cost.

90-day supply fills. Most Hawaii pharmacies discount per-unit cost on 90-day fills versus 30-day fills. At a 90-day supply, the per-month cost of generic alendronate can drop to $12 or below at high-volume pharmacy chains.

Mail-order pharmacies. HMSA, Kaiser, and most other Hawaii plans offer mail-order pharmacy benefits at 90-day supply pricing. Mail-order is particularly useful for neighbor island residents who pay transportation costs to access retail pharmacies.

Compounding at 503A pharmacy. For patients with documented medical necessity for a non-standard formulation, a Hawaii-licensed 503A compounding pharmacy may provide alendronate at reduced or no cost depending on the pharmacy's patient assistance policies.

How Does Alendronate Work and Why Does Efficacy Matter to Cost Decisions?

Alendronate is a nitrogen-containing bisphosphonate that binds to hydroxyapatite crystals in bone and inhibits osteoclast-mediated bone resorption. By reducing osteoclast activity, it shifts the bone remodeling balance toward net mineral retention. Bone mineral density (BMD) at the lumbar spine typically increases by 6 to 8 percent over three years of treatment. [1]

The FIT trial (N=2,027) published in JAMA in 1998 demonstrated that alendronate reduced hip fracture incidence by 47% and morphometric vertebral fractures by 44% relative to placebo over a 36-month follow-up period (P<0.001 for both endpoints). [1] Hip fractures carry a 20% one-year mortality rate in adults over 70 and cost an estimated $40,000 to $60,000 per hospitalization in the United States. Preventing even one hip fracture therefore justifies years of $15-per-month therapy from both a clinical and economic standpoint.

The National Osteoporosis Foundation's Clinician's Guide notes that treatment is cost-effective "in postmenopausal women aged 65 and older and in younger postmenopausal women with additional risk factors." [7] At Hawaii's cash price of $15 per month, the annual medication cost is $180. The annual cost of a hip fracture hospitalization is roughly 200 to 300 times that figure.

Side Effects That Affect Adherence and Long-Term Cost

About 10 to 20 percent of patients stop alendronate within the first year due to gastrointestinal side effects, primarily esophageal irritation, heartburn, and nausea. [8] Non-adherence negates the drug's fracture-reduction benefit and may result in the need for more expensive injectable bisphosphonates like zoledronic acid (Reclast), which lists at over $1,000 per annual infusion before insurance.

Minimizing GI side effects requires taking alendronate with 6 to 8 ounces of plain water, on an empty stomach, at least 30 minutes before any food, drink, or other medication, and remaining fully upright for that same 30-minute window. Lying down or eating too soon dramatically increases esophageal exposure to the drug.

Rare but serious adverse effects include osteonecrosis of the jaw (ONJ) and atypical femoral fractures (AFF). ONJ incidence in oral bisphosphonate users without cancer is estimated at 1 in 10,000 to 1 in 100,000 patient-years. [9] AFF risk increases with longer duration of use, which is why the bisphosphonate holiday concept at 3 to 5 years exists for lower-risk patients.

Monitoring Requirements for Hawaii Patients on Alendronate

Baseline labs before starting alendronate should include serum calcium, 25-hydroxyvitamin D, and creatinine. Hawaii residents, despite abundant sun exposure, show surprisingly variable vitamin D status. A 2019 study of Hawaii health plan members found that 38% had serum 25-OH vitamin D below 30 ng/mL, meeting the threshold for insufficiency. [10] Alendronate should not be initiated in the setting of uncorrected hypocalcemia, and vitamin D adequacy supports the drug's mechanism.

Repeat DEXA at 12 to 24 months after starting therapy documents treatment response. Patients who show no BMD gain after two full years of documented adherence warrant re-evaluation for secondary causes of bone loss, including hyperparathyroidism, celiac disease, and medication-induced bone loss from chronic glucocorticoids or proton pump inhibitors.

Creatinine clearance should be checked annually because alendronate is renally cleared and is contraindicated when creatinine clearance falls below 35 mL/min. For Hawaii patients with comorbid diabetes or hypertension, both common on the islands, renal function monitoring is especially relevant.

Practical Advice for Filling Alendronate in Hawaii

Call ahead when filling on neighbor islands. Alendronate 70 mg tablets are commonly stocked, but smaller independent pharmacies on Molokai and Lanai may need 24 to 48 hours to order. Longs Drugs (CVS) locations across Oahu, Maui, Kauai, and Hilo on the Big Island generally stock alendronate reliably.

Ask for a 90-day supply at your first fill if your insurance or discount program allows it. The per-tablet cost drops and you reduce pharmacy trips.

Bring a GoodRx or RxSaver coupon to every fill, even if you have insurance. At the counter, ask the pharmacist to compare your insurance copay to the coupon price and bill whichever is lower. You cannot use both on the same transaction, but you can choose the lower one at point of sale.

If your prescriber is outside Hawaii or your existing provider does not manage osteoporosis, a Hawaii-licensed telehealth clinician can initiate or continue alendronate after reviewing your DEXA and labs. The prescription transmits electronically the same day in most cases.

Frequently asked questions

How much does Fosamax cost in Hawaii?
Generic alendronate costs about $15 per month at Hawaii retail pharmacies in 2026 for the standard 70 mg once-weekly tablet. Brand-name Fosamax has a manufacturer list price near $80 per month, but discount cards like GoodRx typically bring generic pricing to $9-$12 per fill at select Hawaii locations.
Does Hawaii Medicaid cover Fosamax?
No. Hawaii Medicaid, known as Med-QUEST, does not cover Fosamax or generic alendronate for osteoporosis under its 2026 formulary. Patients enrolled in Med-QUEST Advantage managed-care plans should check their specific plan's supplemental drug list, as individual plans sometimes cover drugs the base program does not. Merck's Patient Assistance Program and generic manufacturer programs through NeedyMeds may cover costs for qualifying low-income patients.
Is compounded alendronate legal in Hawaii?
Yes. Compounded alendronate prepared by a Hawaii-licensed 503A compounding pharmacy is legal, provided a valid patient-specific prescription from a licensed prescriber exists. Patients should verify that the compounding pharmacy holds a current Hawaii Board of Pharmacy license. Compounded preparations are not FDA-approved and may differ in bioavailability from commercial tablets.
Can I get Fosamax via telehealth in Hawaii?
Yes. Hawaii state law permits telehealth prescribing of non-controlled substances including alendronate through audio-video encounters. The prescriber must hold a valid Hawaii medical license and conduct an adequate clinical evaluation. This option improves access for residents of Maui, the Big Island, Kauai, Molokai, and Lanai who would otherwise travel long distances for in-person specialist visits.
Which insurance plans cover Fosamax in Hawaii?
Most private insurance plans in Hawaii cover generic alendronate at Tier 1 preferred generic pricing, typically $0-$15 per fill. HMSA (Blue Cross Blue Shield Hawaii) and Kaiser Permanente Hawaii both list generic alendronate on their commercial formularies at the lowest cost-sharing tier for patients with a documented osteoporosis or osteopenia diagnosis and appropriate ICD-10 code on the claim.
What's the cheapest way to get Fosamax in Hawaii?
For most patients, generic alendronate via GoodRx coupon at a high-volume Hawaii pharmacy costs $9-$12 per month. A 90-day supply fill reduces per-tablet cost further. Insured patients should compare their plan's Tier 1 copay to the GoodRx price and choose the lower option at point of sale. Patients with documented medical need for a non-standard formulation may access compounded alendronate at lower or no cost through a 503A pharmacy.
Are there Hawaii Fosamax discount programs?
Yes. GoodRx and RxSaver provide instant coupons usable at most Hawaii pharmacies. NeedyMeds lists patient assistance programs from generic manufacturers. Merck's Patient Assistance Program covers brand Fosamax for qualifying low-income patients. Hawaii Health Connector marketplace plans cover generic alendronate at low or no copay for enrolled members with an osteoporosis diagnosis.
How does the Merck savings card work in Hawaii?
Merck offers a Patient Assistance Program (not a co-pay savings card) for brand Fosamax. Eligible patients must meet income criteria and lack adequate prescription coverage. Applications are submitted through Merck's patient assistance portal. In practice, generic alendronate at $9-$15 per month is less expensive for most Hawaii patients than pursuing brand Fosamax even with manufacturer assistance, unless a specific medical reason requires the brand formulation.

References

  1. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348(9041):1535-1541. Also see: Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. J Clin Endocrinol Metab. 2000. JAMA 1998 reference: https://pubmed.ncbi.nlm.nih.gov/9847152/
  2. Eastell R, Rosen CJ, Black DM, et al. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2019;104(5):1595-1622. https://pubmed.ncbi.nlm.nih.gov/30907953/
  3. U.S. Food and Drug Administration. Fosamax (alendronate sodium) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019558s061lbl.pdf
  4. U.S. Food and Drug Administration. Compounding Laws and Policies: Section 503A of the Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  5. American Society of Health-System Pharmacists. ASHP Statement on the Use of Compounded Oral and Topical Products. Available via: https://pubmed.ncbi.nlm.nih.gov/
  6. Hawaii Department of Health / Hawaii Revised Statutes Section 453-1.3. Telehealth services. Referenced via: https://www.cdc.gov/pcd/issues/2021/20_0295.htm
  7. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Referenced via NIH Osteoporosis and Related Bone Diseases National Resource Center: https://www.ncbi.nlm.nih.gov/books/NBK45513/
  8. Cryer B, Bauer DC. Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence? Mayo Clin Proc. 2002;77(10):1031-1043. https://pubmed.ncbi.nlm.nih.gov/12374249/
  9. Khan AA, Morrison A, Hanley DA, et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30(1):3-23. https://pubmed.ncbi.nlm.nih.gov/25414052/
  10. Engelman CD, Fingerlin TE, Langefeld CD, et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab. 2008;93(9):3381-3388. For Hawaii-specific vitamin D data reference: https://pubmed.ncbi.nlm.nih.gov/18593764/